Profil
Peter Ordentlich is the founder of Syndax Pharmaceuticals, Inc. since 2005, serving as Chief Scientific Officer.
Former positions include Principal at The Salk Institute for Biological Studies and Research Scientist at X-Ceptor Therapeutics, Inc. Education includes undergraduate and doctorate degrees from the University of Pennsylvania.
Aktiva positioner av Peter Ordentlich
| Företag | Position | Start |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Grundare | 2005-10-11 |
Tidigare kända positioner av Peter Ordentlich
| Företag | Position | Slut |
|---|---|---|
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Företagsledare/Principal | - |
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Peter Ordentlichs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Commercial Services |
















